Filing metadata

Accession number
0001140361-24-023012
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Apr 29, 2024
Reporting period
Apr 26, 2024
Description
Insider transaction

Explore SEC Filings Hub